Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 5.58
+0.08 (1.45%)
At close: Jul 27, 2026
Garofalo Health Care Revenue
Garofalo Health Care had revenue of 132.69M EUR in the quarter ending March 31, 2026, with 3.21% growth. This brings the company's revenue in the last twelve months to 491.21M, up 3.82% year-over-year. In the year 2025, Garofalo Health Care had annual revenue of 487.08M with 3.48% growth.
Revenue (ttm)
491.21M
Revenue Growth
+3.82%
P/S Ratio
1.01
Revenue / Employee
194.00K
Employees
2,714
Market Cap
494.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487.08M | 16.37M | 3.48% |
| Dec 31, 2024 | 470.71M | 102.00M | 27.67% |
| Dec 31, 2023 | 368.70M | 46.13M | 14.30% |
| Dec 31, 2022 | 322.58M | 38.90M | 13.71% |
| Dec 31, 2021 | 283.67M | 72.83M | 34.54% |
| Dec 31, 2020 | 210.85M | 14.31M | 7.28% |
| Dec 31, 2019 | 196.54M | 40.90M | 26.28% |
| Dec 31, 2018 | 155.64M | 18.97M | 13.88% |
| Dec 31, 2017 | 136.67M | 12.58M | 10.14% |
| Dec 31, 2016 | 124.09M | -2.93M | -2.31% |
| Dec 31, 2015 | 127.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| Safilo Group | 983.38M |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Philogen | 319.73M |
| Svas Biosana | 141.56M |